Aileron Therapeutics, Inc. Common Stock ($0.001 par value per share) Capital on Demand™ Sales AgreementAileron Therapeutics Inc • July 1st, 2019 • Pharmaceutical preparations • New York
Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
